The Periodical Third Issue, July 2003

 

 

Editors Note SAGAS Objectives SAGAS News & Website Inauguration In Memory of Dr Bin Huraib
Hypertension & Cerebrovascular Diseases Hypertension Management in Acute Ischemic Stroke The Periodical Quiz The Periodical Case

The Periodical Case

History:

 Physical Examination:

Summary of Investigation: 

 

 

Conclusion: 

Young man with recent Mycoplasma pneumonia infection presented with an acute ischemic stroke with evidence of CNS angiitis and no other clear cause can be detected.

Patient received clacid (an antibiotic with good cover for Mycoplasma spp) and aspirin. He made a tremendous recovery.

 

Mycoplasma Pneumonia: 

Mycoplasma pneumonia is one of the most common cause of atypical pneumonia in collected series from the United States and other part of the world. Mycoplasma pneumonia, Chlamydia, Legionella species have been though to account for 7 to 20% of community acquired pneumonia for which a pathogen can be identified. However, the incidence may be higher for mild cases that can be managed without hospitalization. There are no clinical symptoms, findings, or chest radiograph appearance that reliably distinguish atypical pneumonia from ather pyogenic infection. Additional difficulty in making an etiologic diagnosis in atypical pneumonia is that the pathogen is difficult to culture and diagnosis relies on serological tests. 

Pathogenesis: 

Mycoplasma pneumonia grows under aerobic and aerobic condition. The organism most commonly exists in filamentous form and has adherence protein that attach to epithelial membranes with particular affinity for respiratory tract epithelium. Once attached, mycoplasma pneumonia produces hydrogen peroxide and superoxide causing injury to epithelial cells and their associated cilia. However, many of pathogenic feature of infection with mycoplasma pneumonia are believed to be immune mediated rather than induced directly by the bacteria. This immune mediated mechanism supported by the finding that infant and young children infrequently develops pneumonia despite evidence of infection. 

Epidemiology: 

Infection is ttransmitted from person to person by infected respiratory droplets. Incubation period average 3 weeks. Infection usually occurs in fall and winter seasons. Infection rates are high in school age children, military recruits and college students. The attack rates in families approaches 10% and immunity is not long lasting.  

Clinical Features: 

Many infection due to mycoplasma pneumonia are asymptomatic. Onset of illness is gradual and is usually heralded by headache, malaise and low grade fever. Chills are frequent but rigors are very rare. Patient complaints exceed objective findings since abnormalities on physical examination are Minimal. Clinical manifestation of M. pneumonia divided into those, due to respiratory tract or extrapulmonary disease. 

CNS Manifestation: 

Occurs in approximately 0.1 % of all patient with M. pneumonia and up to 7% of patients requiring hospitalization. CNS involvement occurs most frequently in children and includes aseptic meningitis, meningio-encephalitis, peripheral neuropathy, stroke with angiitis, transverse myelitis, cranial nerve palsy and cerebellar ataxia. In case of CNS involvement due to mycoplasma pneumonia, a history of an antecedent infection is usual, but not always found. 

Chest Radiography: 

Bronchopneumonia, atelactatic changes, nodular infiltration. Most common is prebronchial pneumonia, with predilection for the lower lobes. Pleural effusion occurs in 20% and empyma is rare 

Diagnosis: 

The most used approach for diagnosis is the complement fixation test (CF) which measure early IgM (predominantly) and IgG antibody. Four fold increase in titre in paired sera or a single titire of greater than or equal to 1:32. Major disadvantage of CF test is false positive results. Antigen detection can be performed by antigen capture enzyme immunoassay. Direct PCR detects genomic DNA, and may be highly sensitive and specific for mycoplasma pneumonia.  

Specific Mycoplasma Therapy: 

Doxycycline 100mg twice a day orally or erythromycin 333mg three times orally (both are equally effective) for 2 weeks. No studies have been performed to evaluate effectiveness of alternative therapies in patient with hemolytic anemia or CNS involvement. For CNS disease therapy with steroid, NSAIDS or plasma exchange have been used in addition to antibiotics. 

 

Dr. Mohammed Al-Zawahma

Neurology Resident

Neurology Division

Neurosciences Department

Riyadh Armed Forces Hospital